BioPharmX Corp (BPMX) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 39 transactions totaling $3.7M, demonstrating a bullish sentiment with $883.8K in net insider flow. The most recent transaction on Feb 10, 2020 involved a sale of 55,008 shares valued at $0.
No significant insider buying has been recorded for BPMX in the recent period.
No significant insider selling has been recorded for BPMX in the recent period.
Based on recent SEC filings, insider sentiment for BPMX is bullish with an Insider Alignment Score of 62/100 and a net flow of $883.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BioPharmX Corp (BPMX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading BPMX stock, having executed 39 transactions in the past 90 days. The most active insider is Capital Viii, Llc Vivo (Executive), who has made 4 transactions totaling $1.1M.
Get notified when executives and directors at BPMX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 10, 2020 | Llc Tardimed Sciences | Executive | Sale | 55,008 | $N/A | $0 | |
| Feb 10, 2020 | Llc Tardimed Sciences | Executive | Exercise | 2,255,336 | $N/A | $0 | |
| Feb 10, 2020 | Llc Timber Pharmaceuticals | Executive | Exercise | 2,255,336 | $N/A | $0 | |
| Feb 10, 2020 | Llc Timber Pharmaceuticals | Executive | Sale | 55,008 | $N/A | $0 | |
| Jun 25, 2019 | Viii, Llc Vivo Capital | Executive | Sale | 327,870 | $1.02 | $334.4K | |
| Jan 23, 2019 | B. Krammer Anja | Executive | Sale | 115,874 | $0.11 | $12.7K | |
| Oct 22, 2018 | Morlock Stephen | Executive | Sale | 251,071 | $0.18 | $45.2K | |
| Oct 22, 2018 | Morlock Stephen | Executive | Sale | 220,766 | $0.18 | $39.7K | |
| Oct 19, 2018 | Morlock Stephen | Executive | Sale | 214,091 | $0.18 | $38.5K | |
| Oct 18, 2018 | Morlock Stephen | Executive | Sale | 439,099 | $0.19 | $83.4K | |
| Oct 12, 2018 | B. Krammer Anja | Executive | Sale | 297,500 | $0.19 | $56.5K | |
| Oct 11, 2018 | B. Krammer Anja | Executive | Sale | 100,000 | $0.19 | $19.0K | |
| Oct 10, 2018 | B. Krammer Anja | Executive | Sale | 102,500 | $0.19 | $19.5K | |
| Sep 19, 2018 | S. Tierney David | Executive | Purchase | 100,000 | $0.20 | $20.0K | |
| Mar 7, 2018 | Viii, Llc Vivo Capital | Executive | Sale | 2,000,000 | $0.36 | $720.0K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $2.3M | 58.3% |
Sale(S) | 13 | $1.4M | 36.0% |
Award(A) | 5 | $225.0K | 5.7% |
Exercise (Options)(X) | 2 | $0 | 0.0% |
Conversion(C) | 2 | $0 | 0.0% |
Insiders at BioPharmX Corp are accumulating shares at an accelerated pace. With 8 insiders making 39 transactions totaling $2.3M in purchases versus $1.4M in sales, the net buying activity of $883.8K signals strong executive confidence. Capital Viii, Llc Vivo (Executive) leads the buying activity with $1.1M in transactions across all time.